High density lipoprotein composition influences lymphatic transport after subcutaneous administration.

Interstitial administration (e.g. subcutaneous (SC) administration) of immunotherapies and vaccines within nanoparticles can improve access to lymph-resident immune cells leading to enhanced effica...